Discover
Answers from the Lab
Answers from the Lab
Author: Mayo Clinic Laboratories
Subscribed: 75Played: 3,120Subscribe
Share
© 2022 Mayo Foundation for Medical Education and Research. All rights reserved.
Description
A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.
392 Episodes
Reverse
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss a new collaboration and a Mayo Clinic-led study focused on detecting DNA mutations. Later, Dr. Pritt welcomes Andrew McKeon, M.B., B.Ch., M.D., and Anastasia Zekeridou, M.D., Ph.D., co-directors of Mayo Clinic’s Neuroimmunology Laboratory, to discuss how they are advancing patient care.Expanding access to advanced testing (00:32): Discover how a new collaboration with Pathology Asia Holdings will expand access to molecular and genomic testing.Advancing DNA mutation detection (04:50): Hear about research to detect DNA mutations across the genome and its potential implications for clinical diagnostics.Innovating in autoimmune neurology (07:39): Learn how the unique dynamics of the Mayo Clinic Neuroimmunology Laboratory help drive innovation. ResourcesPhenotype-specific approach transcends traditional testing for autoimmune neurological conditionsAutoimmune neurology: At the forefront of a testing evolutionMayo Clinic Laboratories invests in Pathology Asia Holdings and LifeStrands Genomics to advance diagnostics and precision medicineSomatic mutations: Study advances DNA detection
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss the future of diagnostics. Later, Eric Hsi, M.D., chair of Mayo Clinic’s Department of Laboratory Medicine and Pathology in Rochester, shares how the department is advancing innovation and helping transform healthcare through laboratory medicine.Trends shaping the future of diagnostics (00:31): Dr. Morice discusses the scientific advances, emerging technologies, and evolving patient expectations that are shaping the future of clinical diagnostics.Laboratory transformation and innovation at Mayo Clinic (08:20): Dr. Hsi discusses his perspective on laboratory medicine's role in healthcare transformation and how his team approaches innovation across Mayo Clinic. Hematopathology advances (18:08): As a leader in hematopathology, Dr. Hsi shares the advances he is most excited about for their ability to improve patient care. Resources”Answers From the Lab” podcast: Get to Know the DLMP Chair: Eric Hsi, M.D.Dr. Bill Morice explores trends transforming diagnostics
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Mayo Clinic’s new collaboration with Thermo Fisher and the latest on the Protecting Access to Medicare Act (PAMA). Later, Dr. Pritt welcomes Matt Binnicker, Ph.D., Mayo Clinic Laboratories’ chief scientific officer and a leader in novel diagnostics for viral infections, to explore seasonal virus activity. Mayo Clinic and Thermo Fisher collaboration (00:29): Explore how this initiative is turning early biological signals into opportunities for prevention, diagnosis, and treatment.PAMA preliminary rates (04:20): Get an overview of CMS's preliminary 2027 Medicare Clinical Laboratory Fee Schedule based on data collected through PAMA.Virus update and outlook (08:30): Learn what experts are predicting for seasonal viruses this winter. Testing stewardship and innovation (15:43): Discover guidance for seasonal virus testing and how new advances are improving detection.ResourcesMayo Clinic News Network: Clinic and Thermo Fisher Scientific launch Precure, LLC to identify signs of disease before symptoms appearCMS: Preliminary Calendar Year (CY) 2027 Medicare Clinical Laboratory Fee Schedule Payment RatesRespiratory viruses: Testing for early detection
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss seasonal vaccination planning and survey findings on laboratory industry growth. Later, Leslie Donato, Ph.D., a clinical chemist at Mayo Clinic, shares how an innovative testing panel is improving the diagnosis of bile acid malabsorption.Survey highlights laboratory growth strategies (00:29): Discover where laboratory leaders are investing, the challenges shaping the industry, and the strategies organizations are adopting to achieve sustainable growth.Seasonal viruses and vaccination planning (05:29): Discover how to learn more about vaccination options for viruses that typically surge during the fall and winter.Diagnostics for chronic diarrhea (07:43): Hear how a novel test is improving diagnosis and advancing understanding of bile acid malabsorption.ResourcesSurvey reveals four strategies for laboratory growthVaccine and immunization guidance from Mayo ClinicTesting Options for Patients with Chronic Diarrhea: A Focus on Bile Acid Malabsorption WebinarBile acid malabsorption: A patient-centered approach to diagnose a common cause of chronic diarrheaThe right testing for an underrecognized cause of chronic diarrhea
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss advancement in Alzheimer’s testing and practical uses of artificial intelligence (AI) in healthcare. Later, Dr. Pritt welcomes Chris Garcia, M.D., Mayo Clinic Laboratories’ chief digital innovation officer, to explore the evolving role of data in research and development. Innovative Alzheimer’s test gets FDA clearance (00:33): Dr. Morice shares how a strategic collaboration is enabling Mayo Clinic Laboratories to offer a newly FDA-cleared blood test for Alzheimer’s disease for adults with cognitive symptoms as young as 40.AI helping diagnose rare diseases (03:37): Dr. Pritt and Dr. Morice reflect on a recent article highlighting how AI is helping clinicians identify rare diseases.Data use in research and development (08:16): Dr. Garcia discusses how data, AI, and cross-disciplinary collaboration are advancing research and innovation in laboratory medicine. Note: Information in this post was accurate at the time of its posting.ResourcesC2N Diagnostics: FDA clears C2N Diagnostics’ PrecivityAD2® —First Alzheimer’s blood test for adults with cognitive symptoms as young as 40Wall Street Journal: AI is helping patients solve medical mysteriesAnswers From the Lab: Digital Advances: What's Next for Clinical Diagnostics?Answers From the Lab: Accelerating Research and Development With BioPharma Diagnostics








